2020, Number 4
<< Back Next >>
Acta Med 2020; 18 (4)
Bullous pemphigoid associated with rivaroxaban use
Martínez MAC, Castrejón PG, Hernández SD, Valencia LR
Language: Spanish
References: 5
Page: 422-423
PDF size: 140.86 Kb.
Text Extraction
No abstract.
REFERENCES
Shim J, Chung S, Kim B, Kim S, Lee K, Yoon Y, Chang Y. Bullous hemorrhagic dermatosis due to enoxaparin use in a bullous pemphigoid patient. Asia Pac Allergy. 2017; 7: 97-101.
Ferreira C, Oliveira A, Furtado A, Rocha A, Ribeiro J. Bullous pemphigoid-like skin eruption during treatment with rivaroxaban: a clinical case study. Eur J Case Rep Intern Med. 2018; 5 (3): 000724.
Eek A, Oddvar B, Bakkehoi G, Stenberg-Nilsen H. Anticoagulant-associated adverse drug reactions in 2013-15. Tidsskr Nor Laegeforen. 2018; 138 (12).
Vu TT, Gooderham M. Adverse drug reactions and cutaneous manifestations associated with anticoagulation. J Cutan Med Surg. 2017; 21 (6): 540-550.
Dyson SW, Lin C, Jaworsky C. Enoxaparin sodium-induced bullous pemphigoid-like eruption: a report of 2 cases. J Am Acad Dermatol. 2004; 51 (1): 141-412.
Full text
10.35366/97272